Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T436-147777 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2030-042 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T436-142222 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N30-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-33 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01D15-08 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-88 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-33 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D237-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01D15-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-04 |
filingDate |
1999-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2006-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2006-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-100661772-B1 |
titleOfInvention |
Reference Compound for Lebocymendan Batch Analysis |
abstract |
The present invention relates to pyridazinyl compound (I) and its use as reference material in the determination of potentially genotoxic impurities in a lebocymendan sample. The present invention also relates to an analytical method for determining potentially genotoxic impurities in a levocimendane sample using compound (I) as reference compound. Lebocymendan is a useful drug for the treatment of heart attacks.n n n (I)n n n n Lebocymendan, Reference Substance, Impurities |
priorityDate |
1998-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |